Trends in distant-stage breast, colorectal, and prostate cancer incidence rates from 1992 to 2004: Potential influences of screening and hormonal factors

Hormones and Cancer

Volumn 1, Issue 1, 2010, Pages 55-62

  McDougall, Jean A ^a   Li, Christopher I ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

Author keywords

Breast; Colon; Disparities; Prostate; Trends

Indexed keywords

HORMONE RECEPTOR; SEX HORMONE;

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; DISEASE SURVEILLANCE; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SEX RATIO; TREND STUDY;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HORMONES; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PROSTATIC NEOPLASMS; SEER PROGRAM;

EID: 78650220214     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-009-0002-1     Document Type: Article

References (34)

1. Boyer-Chammard A, Taylor TH, Anton-Culver H (1999) Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev 23(6):463-473
2. Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94(7):490-496
3. Joslyn SA, West MM (2000) Racial differences in breast carcinoma survival. Cancer 88(1):114-123
4. Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97(1):134-147
5. Cress RD, Morris CR, Wolfe BM (2000) Cancer of the colon and rectum in California: trends in incidence by race/ethnicity, stage, and subsite. Prev Med 31(4):447-453
6. Chu KC, Tarone RE, Freeman HP (2003) Trends in prostate cancer mortality among black men and white men in the United States. Cancer 97(6):1507-1516
7. Merrill RM, Lyon JL (2000) Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology 55(5):730-735
8. Jones BA, Liu WL, Araujo AB, Kasl SV, Silvera SN, Soler-Vila H et al (2008) Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev 17(10):2825-2834
9. Elledge RM, Clark GM, Chamness GC, Osborne CK (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86(9):705-712
10. Elmore JG, Moceri VM, Carter D, Larson EB (1998) Breast carcinoma tumor characteristics in black and white women. Cancer 83(12):2509-2515
11. Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11(7):601-607
12. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492-2502
13. Powell IJ, Banerjee M, Sakr W, Grignon D, Wood DP Jr, Novallo M et al (1999) Should African-American men be tested for prostate carcinoma at an earlier age than white men? Cancer 85 (2):472-477
14. Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9(1):R6
15. Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA et al (1999) Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen- detected cancers. J Natl Cancer Inst 91(23):2020-2028
16. Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE et al (2005) A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 14(5):1108-1112
17. Rohrmann S, Sutcliffe CG, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G et al (2009) Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates. Cancer Epidemiol Biomarkers Prev 18(5):1484-1491
18. Winters SJ, Brufsky A, Weissfeld J, Trump DL, Dyky MA, Hadeed V (2001) Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism 50(10):1242-1247
19. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW et al (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89(2):166-170
20. Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H et al (1998) Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 58(20):4497-4504
21. Travis RC, Schumacher F, Hirschhorn JN, Kraft P, Allen NE, Albanes D et al (2009) CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 18(10):2734-2744
22. Ries LAG, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK (eds) (2008) SEER cancer statistics review, 1975-2005. National Cancer Institute, Bethesda
23. Young J, Roffers S, Ries L, Fritz A, Hurlbut A (2001) SEER summary staging manual-2000: codes and coding instructions. National Cancer Institute, Bethesda
24. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med 19(3):335-351
25. Harper S, Lynch J (2005) Methods for measuring cancer disparities: a review using data relevant to healthy people 2010 cancer-related objectives. National Institutes of Health, Bethesda
26. Anderson WF, Reiner AS, Matsuno RK, Pfeiffer RM (2007) Shifting breast cancer trends in the United States. J Clin Oncol 25 (25):3923-3929
27. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56(3):168-183
28. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC (2003) Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.Cancer 97(6):1528-1540
29. Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA (2004) Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer 101(7):1490-1500
30. Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA et al (2003) Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years. Cancer Epidemiol Biomarkers Prev 12(11 Pt 1):1175-1181
31. Chu KC, Tarone RE, Chow WH, Alexander GA (1995) Colorectal cancer trends by race and anatomic subsites, 1975 to 1991. Arch Fam Med 4(10):849-856
32. Drake BF, Lathan CS, Okechukwu CA, Bennett GG (2008) Racial differences in prostate cancer screening by family history. Ann Epidemiol 18(7):579-583
33. Wingo PA, Jamison PM, Hiatt RA, Weir HK, Gargiullo PM, Hutton M et al (2003) Building the infrastructure for nationwide cancer surveillance and control-a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control 14(2):175-193
34. Clegg LX, Reichman ME, Hankey BF, Miller BA, Lin YD, Johnson NJ et al (2007) Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 18(2):177-187